BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

AtomVie Supplies First Patient Dose In Radiopharm Theranostics Phase 1 2a Study Of 177Lu BetaBart

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first pat...

February 26, 2026 | News

Catalent And S Biomedics Partner To Advance Stem Cell Therapy For Parkinsons Disease

Catalent and S.Biomedics announced a strategic partnership to support the development and manufacturing of TED‑A9, S.Biomedics’ allogeneic pluripot...

February 23, 2026 | News

Syngene Partners With Johns Hopkins To Accelerate Early Stage Drug Discovery

Syngene International, a global contract research, development, and manufacturing organization (CRDMO) announced a strategic collaboration with Johns Hopki...

February 13, 2026 | News

Thermo Fisher Scientific And Datavant Partner To Advance Connected Real World Evidence In Clinical Research

Thermo Fisher Scientific, the world leader in serving science,announced a strategic data collaboration with Datavant, the data collaboration platform trust...

February 12, 2026 | News

Merck Strengthens India As A Strategic Healthcare R&D Growth Engine With New Innovation Hub

A workplace designed for long-term growth, efficiency, and innovation Elevating Merck Healthcare’s R&D India Hub as a premier talent powerho...

February 02, 2026 | News

Turning Frontline Reality Into Policy Action For Cancer Care In Asia

Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...

February 02, 2026 | Expert Insight

Fidēs Launches Science Led Imaging CRO Focused On Early Phase Clinical Decision Making

Fidēs announced its launch as a new imaging contract research organization (iCRO) designed specifically for early-phase clinical development, where imagin...

February 02, 2026 | News

Dr Chris Chen Positions WuXi Biologics As The Defining Force Shaping The Future Of Global CRDMO Innovation

Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...

January 19, 2026 | News

Fresenius Kabi And TQ Therapeutics Sign Strategic Agreement To Scale T Cell Manufacturing For Cell And Gene Therapy

Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under...

January 16, 2026 | News

WuXi Biologics Secures UK MHRA GMP Clearance For Wuxi Ophthalmic Manufacturing Sites

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...

January 14, 2026 | News

Thermo Fisher Scientific Enrols First Patient In New CorEvitas Obesity Registry

Thermo Fisher Scientific Inc., the world leader in serving science,announced the enrollment of the first patient in the new PPD™ CorEvitas™ Obe...

January 08, 2026 | News

C&R Research Deepens Indonesia Engagement Through Global Clinical Trial Capabilities

Accelerating Indonesia Collaboration through Global Clinical Capabilities C&R Research, founded in 1997 as Korea's first full-service Contract R...

January 06, 2026 | News

Fujifilm Corporation Completes Major Bio CDMO Manufacturing Hub In Japan To Strengthen Asia Biologics Supply

FUJIFILM Corporation announced the completion of one of Japan’s largest bio CDMO facilities (the new plant) at the Toyama Second Factory ...

December 30, 2025 | News

Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site

- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...

December 22, 2025 | News

Stay Connected